Finasteride vs Ketoconazole
FDA Approved vs FDA Approved
synergistic Researched · 95% Core combination in the "big 3" hair loss stack. Finasteride reduces systemic and scalp DHT production via 5-alpha reductase inhibition, while ketoconazole disrupts DHT binding locally at the follicle and reduces scalp inflammation. The two target hair loss through complementary mechanisms.
Molecular Data
Finasteride Ketoconazole
Weight 372.54 Da 531.43 Da
Half-life 6-8 hours (DHT suppression persists ~24 hours) Topical application stays local with minimal systemic absorption
Type Synthetic 4-azasteroid compound Synthetic imidazole antifungal
Key Benefits
Finasteride
01 Reduces scalp DHT by approximately 66% at 1mg daily
02 Slows or stops hair loss progression in roughly 90% of men
03 Produces visible hair regrowth in approximately 48% of men within 1-2 years
04 FDA-approved with over 25 years of clinical use and long-term safety data
05 Convenient once-daily oral dosing with no injections required
06 Well-characterized side effect profile with low incidence of adverse events
07 Can be combined with minoxidil for enhanced efficacy
Ketoconazole
01 Disrupts DHT binding at the follicle level with topical application
02 Reduces Malassezia colonization and scalp inflammation associated with hair loss
03 Negligible systemic absorption when used as a shampoo
04 FDA-approved and widely available over the counter (1%) or by prescription (2%)
05 Part of the established "big 3" hair loss protocol with finasteride and minoxidil
06 Treats concurrent seborrheic dermatitis and dandruff while addressing hair loss
07 Simple to incorporate into existing shower routines
Side Effects
Finasteride
Decreased libido (reported in 1.8% of men in clinical trials vs 1.3% placebo)
Erectile dysfunction (reported in 1.3% vs 0.7% placebo)
Decreased ejaculate volume (reported in 0.8% vs 0.4% placebo)
Ketoconazole
Scalp dryness with regular use
Mild scalp irritation or itching at application site
Changes in hair texture (temporary dryness or coarseness)
Contraindications
Women who are pregnant or may become pregnant (finasteride is teratogenic and can cause abnormalities of external genitalia in a male fetus; even handling crushed tablets poses a risk)
Women who are breastfeeding
Known hypersensitivity to finasteride or any component of the formulation
Severe hepatic impairment (finasteride is metabolized by the liver)
Pediatric patients (not indicated for use in children)
Known hypersensitivity to ketoconazole or any imidazole antifungal
Open wounds or severely broken skin on the scalp
Oral ketoconazole is contraindicated in liver disease (not applicable to shampoo use)
Research Evidence
Finasteride Ketoconazole
Status FDA Approved FDA Approved
References 5 studies 4 studies
FDA Approved Yes Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.